Lucid Diagnostics Inc, a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed In , announced that, the MolDX Program published a Future Effective...
The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to automatically detect and segment...
Theralink Technologies, Inc, a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, announced that it has acquired an exclusive...
ThreatHunter.ai has created an innovative cybersecurity solution to address the common challenges faced by companies, including alert fatigue, improper system tuning, outdated threat intelligence,...
Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.
"Mozarc...
